LCP1 Antikörper

Produktnummer ABIN6252300

Dieses Maus Monoklonal-Antikörper erkennt spezifisch LCP1 in ELISA, IF und ICC. Er zeigt eine Reaktivität gegenüber Human Herpesvirus 5 (HHV-5).

Kurzübersicht für LCP1 Antikörper (ABIN6252300)

Target: LCP1 (Lymphocyte Cytosolic Protein 1 (LCP1))

Reaktivität: Human Herpesvirus 5 (HHV-5)

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Dieser LCP1 Antikörper ist unkonjugiert

Applikation: ELISA, Immunofluorescence (IF), Immunocytochemistry (ICC)

Klon: CMV101

Produktdetails anti-LCP1 Antikörper

Aufreinigung: Protein G affinity chromatography

Immunogen: Recombinant Cytomegalovirus p65 protein was used as the immunogen for this PP65 antibody.

Isotyp: IgG1 kappa

Anwendungsinformationen

Applikationshinweise: ELISA: order BSA-free format for coating

Immunocytochemistry (Acetone or paraformaldehyde fixed): 0.5-1 μg/mL for 30 min

IF: 0.5-1 μg/mL

The concentration stated for each application is a general starting point. Variations in protocols, secondaries and substrates may require the PP65 antibody to be titered up or down for optimal performance.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 0.2 mg/mL

Buffer: PBS with 0.1 mg/mL BSA and 0.05 % sodium azide

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C

Informationen zur Lagerung: Aliquot and Store at -20C. Avoid freez-thaw cycles.

Details zu LCP1

Target: LCP1 (Lymphocyte Cytosolic Protein 1 (LCP1))

Andere Bezeichnung: PP65

Hintergrund: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop cytomegalovirus (CMV) infections. In some patients with AIDS, cytomegalovirus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of cytomegalovirus disease. An indicator of active CMV infection is needed to facilitate the diagnosis of cytomegalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus p65 antigen was detected in the leukocytes of both the peripheral blood and BALF during the early phase of CMV disease.